Exchange Traded Concepts, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

$10.4 Billion
Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 2,073 shares of ALNY stock, worth $982,602. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,073

Previous 2,806 26.12%

Holding current value

$982,602

Previous $915,000 3.28%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$311.12 - $482.13 $228,050 - $353,401	-733 Reduced 26.12%	2,073 $945,000
Q2 2025 Jul 10, 2025	SELL	$224.32 - $326.09 $203,906 - $296,415	-909 Reduced 24.47%	2,806 $915,000
Q1 2025 Apr 17, 2025	SELL	$233.07 - $290.7 $27,502 - $34,302	-118 Reduced 3.08%	3,715 $1 Million
Q4 2024 Jan 21, 2025	BUY	$232.27 - $300.43 $61,551 - $79,613	265 Added 7.43%	3,833 $901,000
Q3 2024 Oct 10, 2024	BUY	$233.81 - $287.01 $31,798 - $39,033	136 Added 3.96%	3,568 $981,000
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $51,018 - $87,932	-356 Reduced 9.4%	3,432 $833,000
Q1 2024 Apr 15, 2024	SELL	$146.51 - $198.2 $238,078 - $322,075	-1,625 Reduced 30.02%	3,788 $566,000
Q4 2023 Jan 05, 2024	BUY	$151.41 - $196.57 $308,876 - $401,002	2,040 Added 60.48%	5,413 $1.04 Million
Q3 2023 Oct 18, 2023	SELL	$170.77 - $211.65 $829,942 - $1.03 Million	-4,860 Reduced 59.03%	3,373 $597,000
Q2 2023 Jul 20, 2023	SELL	$185.01 - $212.05 $2.41 Million - $2.76 Million	-13,035 Reduced 61.29%	8,233 $1.56 Million
Q1 2023 Apr 12, 2023	BUY	$182.66 - $235.53 $2.54 Million - $3.27 Million	13,900 Added 188.65%	21,268 $4.26 Million
Q4 2022 Jan 17, 2023	SELL	$185.53 - $241.31 $134,323 - $174,708	-724 Reduced 8.95%	7,368 $1.75 Million
Q3 2022 Oct 07, 2022	SELL	$138.54 - $232.0 $715,004 - $1.2 Million	-5,161 Reduced 38.94%	8,092 $1.62 Million
Q2 2022 Jul 20, 2022	SELL	$120.42 - $169.29 $33,597 - $47,231	-279 Reduced 2.06%	13,253 $1.93 Million
Q1 2022 Apr 26, 2022	BUY	$127.18 - $173.91 $587,317 - $803,116	4,618 Added 51.81%	13,532 $2.21 Million
Q4 2021 Jan 13, 2022	SELL	$159.56 - $209.29 $28,242 - $37,044	-177 Reduced 1.95%	8,914 $1.51 Million
Q3 2021 Oct 18, 2021	SELL	$169.75 - $207.73 $338,990 - $414,836	-1,997 Reduced 18.01%	9,091 $1.72 Million
Q2 2021 Jul 30, 2021	BUY	$128.63 - $176.89 $44,248 - $60,850	344 Added 3.2%	11,088 $1.88 Million
Q1 2021 Apr 20, 2021	BUY	$126.83 - $175.69 $427,163 - $591,723	3,368 Added 45.66%	10,744 $1.52 Million
Q4 2020 Jan 19, 2021	BUY	$122.97 - $147.0 $569,228 - $680,463	4,629 Added 168.51%	7,376 $959,000
Q3 2020 Oct 30, 2020	BUY	$121.19 - $165.49 $154,153 - $210,503	1,272 Added 86.24%	2,747 $400,000
Q2 2020 Jul 15, 2020	BUY	$104.21 - $156.44 $80,033 - $120,145	768 Added 108.63%	1,475 $218,000
Q1 2020 Apr 14, 2020	BUY	$93.12 - $133.99 $30,077 - $43,278	323 Added 84.11%	707 $77,000
Q4 2019 Jan 22, 2020	BUY	$74.51 - $124.23 $28,611 - $47,704	384 New	384 $44,000

Others Institutions Holding ALNY

# of Institutions

775

Shares Held

115M

Call Options Held

584K

Put Options Held

661K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $58.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Alnylam Pharmaceuticals, Inc. Transaction History